Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189–3202
Article CAS PubMed PubMed Central Google Scholar
Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC et al (2016) Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 19(4):448–457
Article CAS PubMed PubMed Central Google Scholar
Hannon AM, Thompson CJ, Sherlock M (2017) Diabetes in patients with acromegaly. Curr Diab Rep 17(2):8
Article CAS PubMed Google Scholar
Rodrigues TC, Costenaro F, Fedrizzi D, Oliveira MD, Lima PB, Boschi V et al (2011) Diabetes mellitus in a cohort of patients with acromegaly. Arq Bras Endocrinol Metabol 55(9):714–719
Jonas C, Maiter D, Alexopoulou O (2016) Evolution of glucose tolerance after treatment of Acromegaly: a study in 57 patients. Horm Metab Res 48(5):299–305
Article CAS PubMed Google Scholar
Fieffe S, Morange I, Petrossians P, Chanson P, Rohmer V, Cortet C et al (2011) Diabetes in acromegaly, prevalence, risk factors, and evolution: data from the French Acromegaly Registry. Eur J Endocrinol 164(6):877–884
Article CAS PubMed Google Scholar
Alexopoulou O, Bex M, Kamenicky P, Mvoula AB, Chanson P, Maiter D (2014) Prevalence and risk factors of impaired glucose tolerance and diabetes mellitus at diagnosis of acromegaly: a study in 148 patients. Pituitary 17(1):81–89
Article CAS PubMed Google Scholar
Clemmons DR (2002) Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 5(3):181–183
Article CAS PubMed Google Scholar
Katznelson L, Laws ER Jr., Melmed S, Molitch ME, Murad MH, Utz A et al (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951
Article CAS PubMed Google Scholar
Melmed S (2006) Medical progress: Acromegaly. N Engl J Med 355(24):2558–2573
Article CAS PubMed Google Scholar
Jaffrain-Rea ML, Minniti G, Moroni C, Esposito V, Ferretti E, Santoro A et al (2003) Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly. Eur J Endocrinol 148(2):193–201
Article CAS PubMed Google Scholar
Kinoshita Y, Fujii H, Takeshita A, Taguchi M, Miyakawa M, Oyama K et al (2011) Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic beta-cell function is preserved. Eur J Endocrinol 164(4):467–473
Article CAS PubMed Google Scholar
Tzanela M, Vassiliadi DA, Gavalas N, Szabo A, Margelou E, Valatsou A et al (2011) Glucose homeostasis in patients with acromegaly treated with surgery or somatostatin analogues. Clin Endocrinol (Oxf) 75(1):96–102
Article CAS PubMed Google Scholar
He W, Yan L, Wang M, Li Q, He M, Ma Z et al (2019) Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases. Endocrine 63(1):27–35
Article CAS PubMed Google Scholar
Araujo-Castro M, Biagetti B, Menendez Torre E, Novoa-Testa I, Cordido F, Pascual Corrales E et al (2024) Differences between GH and PRL co-secreting and GH-secreting pituitary adenomas. A series of 604 cases. J Clin Endocrinol Metab
Fleseriu M, Biller BMK, Freda PU, Gadelha MR, Giustina A, Katznelson L et al (2021) A Pituitary Society update to acromegaly management guidelines. Pituitary 24(1):1–13
Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K et al (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85(2):526–529
Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF et al (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95(7):3141–3148
Article CAS PubMed Google Scholar
ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D et al (2023) 2. Classification and diagnosis of diabetes: standards of Care in Diabetes-2023. Diabetes Care 46(Suppl 1):S19–S40
Article CAS PubMed Google Scholar
Riddle MC, Cefalu WT, Evans PH, Gerstein HC, Nauck MA, Oh WK et al (2021) Consensus Report: definition and interpretation of Remission in Type 2 diabetes. Diabetes Care 44(10):2438–2444
Article CAS PubMed PubMed Central Google Scholar
Obesity (2000) Preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:i–xii
Magliano DJ, Boyko EJ (2021) IDF DIABETES ATLAS. IDF Diabetes Atlas. 10th ed. Brussels
Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152
Article CAS PubMed Google Scholar
Li YL, Zhang S, Guo XP, Gao L, Lian W, Yao Y et al (2019) Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China. Arch Endocrinol Metab 63(2):157–166
PubMed PubMed Central Google Scholar
Moller N, Jorgensen JO (2009) Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev 30(2):152–177
Li X, Tang J, Lin S, Liu X, Li Y (2024) Mendelian randomization analysis demonstrates the causal effects of IGF family members in diabetes. Front Med (Lausanne) 11:1332162
Sandhu MS (2005) Insulin-like growth factor-I and risk of type 2 diabetes and coronary heart disease: molecular epidemiology. Endocr Dev 9:44–54
Article CAS PubMed Google Scholar
Helseth R, Carlsen SM, Bollerslev J, Svartberg J, Oksnes M, Skeie S et al (2016) Preoperative octreotide therapy and surgery in acromegaly: associations between glucose homeostasis and treatment response. Endocrine 51(2):298–307
Article CAS PubMed Google Scholar
Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio G et al (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91(1):85–92
Article CAS PubMed Google Scholar
Colao A, Auriemma RS, Galdiero M, Cappabianca P, Cavallo LM, Esposito F et al (2009) Impact of somatostatin analogs versus surgery on glucose metabolism in acromegaly: results of a 5-year observational, open, prospective study. J Clin Endocrinol Metab 94(2):528–537
Article CAS PubMed Google Scholar
Ronchi CL, Varca V, Beck-Peccoz P, Orsi E, Donadio F, Baccarelli A et al (2006) Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors. J Clin Endocrinol Metab 91(1):121–128
Article CAS PubMed Google Scholar
Moller N, Schmitz O, Joorgensen JO, Astrup J, Bak JF, Christensen SE et al (1992) Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy. J Clin Endocrinol Metab 74(5):1012–1019
Stelmachowska-Banas M, Zielinski G, Zdunowski P, Podgorski J, Zgliczynski W (2011) The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly. Neurol Neurochir Pol 45(4):328–334
留言 (0)